Enzalutamide-Induced Upregulation of PCAT6 Promotes Prostate Cancer Neuroendocrine Differentiation by Regulating miR-326/HNRNPA2B1 Axis

Our previous studies have demonstrated that Enzalutamide-induced upregulation of long non-coding RNA p21 (lncRNA-p21) facilitates prostate cancer (PCa) neuroendocrine differentiation (NED). Given the important role of lncRNAs in PCa pathogenesis, and given that lots of lncRNAs are dys-regulated in n...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bo, Jiang, Hui-Yang, Yuan, Tao, Luo, Jie, Zhou, Wei-Dong, Jiang, Qi-Quan, Wu, Denglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278330/
https://www.ncbi.nlm.nih.gov/pubmed/34277403
http://dx.doi.org/10.3389/fonc.2021.650054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8278330/
https://www.ncbi.nlm.nih.gov/pubmed/34277403
http://dx.doi.org/10.3389/fonc.2021.650054

Ejemplares similares